Fundraising Fox
Synnovation Therapeutics
Wilmington, US · Founded 2021 · Delaware corporation · 49 employees on LinkedIn · 3 known investors
Find your way into Synnovation Therapeutics
Sign up to see every warm intro you have to Synnovation Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synnovation Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
Founders & leadership
Synnovation Therapeutics was founded in 2021 by Liangxing Wu and Wenqing Yao.
Board
Investors · 3
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: The Innovation Space's portfolio page · Not right? Tell us
How we know: Third Rock Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$52M disclosed across 3 rounds · 2021–2023
▶$15MraisedDec 2023 · 7 investors · BiotechnologyRule 506(b)
- Liangxing WuExecutive Officer, Director
- Wenqing YaoExecutive Officer, Director
- Reid HuberDirector
- Ting FengDirector
- Offering amount
- $102.5M
- Amount sold
- $15M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$25MraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
- Liangxing WuExecutive Officer, Director
- Reid HuberDirector
- Ting FengDirector
- Wenqing YaoExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$12MraisedNov 2021 · 1 investors · BiotechnologyRule 506(b)
- Wenqing YaoExecutive Officer, Director
- Liangxing WuExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Synnovation Therapeutics.
Frequently asked questions
- What does Synnovation Therapeutics do?
- A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
- Who founded Synnovation Therapeutics?
- Synnovation Therapeutics was founded by Liangxing Wu, Wenqing Yao in 2021.
- Who are Synnovation Therapeutics's investors?
- Synnovation Therapeutics's investors include Nextech Invest, The Innovation Space, Third Rock Ventures.
- How much funding has Synnovation Therapeutics raised?
- Synnovation Therapeutics has disclosed $52M raised across 3 rounds.
- Where is Synnovation Therapeutics headquartered?
- Synnovation Therapeutics is headquartered in Wilmington, US.